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Abstract 
Background: We sought to investigate the impact of incomplete revascularization (IR) on 
long-term survival after isolated coronary artery bypass grafting (CABG) by analysing 20 years 
single institution data. The emphasis of this study is large sample size, focus on the extent of 
IR and long term follow-up. 
Methods and Results: A total of 13,701 patients with multivessel disease undergoing CABG 
were included in the analysis. All patients received left internal thoracic artery (LITA) to the 
left anterior descending artery (LAD) territory. IR of the right coronary artery (RCA) and/or 
the circumflex (CX) artery was defined as at least one diseased arterial territory incompletely 
revascularized. Overall 3,107 (22.7%) patients received IR. After propensity score matching, 
IR did not increase all cause death in the overall group (HR 1.09; 95%CI 0.96-1.22; P=0.17). 
However, when both RCA and CX artery were incompletely revascularized, late survival was 
significantly lower (HR 2.15; 95%CI 1.57-2.93).  IR was associated with a higher risk of death 
after off-pump (HR 1.26; 95%CI 1.05-1.49) regardless the extent of IR. After on-pump, IR 
significantly affected survival only when both RCA and CX artery only were incompletely 
revascularized (HR 2.32; 95%CI 1.27-4.22). 
Conclusions: The present analysis showed that the impact of IR on survival is marginal when 
the procedure is performed with the use of cardiopulmonary bypass while IR after off-pump 
CABG remains associated with significantly lower survival. The worst survival rates are 
observed when both RCA and CX artery remain incompletely revascularized. 
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Despite complete revascularization (CR) has long been considered the goal of coronary artery 
bypass graft (CABG) surgery [1] this is not always achieved due to procedural difficulties [2]. 
The impact of incomplete revascularization (IR) on long term survival remains uncertain [2,3]. 
No randomized controlled trial has ever tested whether CR is superior to incomplete 
revascularization (IR) and results from observational cohorts are conflicting [2-7]. What 
remains unclear is whether different degrees of IR can have different effect on survival. 
Moreover, patients who undergo IR are more likely to present multiple comorbidities and this 
could bias the data in favour of complete revascularization. Finally several comparisons 
between IR and CR strategies report mid-term results only [2,3] and longer follow-up might be 
necessary for IR to show its detrimental effect on survival [4].  
We sought to investigate the impact of IR on long-term survival after isolated CABG by 
analysing 20 years single institution data. The emphasis of this study is large sample size, focus 
on the extent of IR and long term follow-up. 
Methods 
The study was conducted in accordance with the principles of the Declaration of Helsinki. The 
local audit committee approved the study, and the requirement for individual patient consent 
was waived. We retrospectively analysed prospectively collected data from The National 
Institute for Cardiovascular Outcomes Research (NICOR) registry on 1 June 2015 for all 
isolated first time CABG procedures performed at the Bristol Heart Institute, Bristol United 
Kingdom from 1996 to April 2015.  Reproducible cleaning algorithms were applied to the 
database, which are regularly updated as required. Briefly, duplicate records and non-adult 
cardiac surgery entries were removed; transcriptional discrepancies harmonized; and clinical 
conflicts and extreme values corrected or removed. The data are returned regularly to the local 
units for validation.  
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Further details and definition of variables are available at 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets. During the study period, a total of 
15,119 patients underwent first time isolated CABG; 931 subjects operated for single vessel 
disease were excluded; information on the use of cardiopulmonary bypass (on-pump vs off-
pump) was not available in 487 cases which were excluded. A total of 13,701 subjects were 
included in the final analysis. All patients received left internal thoracic artery (LITA) to the 
left anterior descending artery (LAD) territory. The incidence of incomplete revascularization 
(IR) of the right coronary artery (RCA) and/or the circumflex (CX) artery was defined as at 
least one diseased arterial territory incompletely revascularized. Overall 3,107 (22.7%) and 
10,594 patients (78.8%) received IR and CR respectively.   
Pre-treatment variables    
The effect of OPCAB on outcomes of interest was adjusted for the following pre-treatment 
variables including: age, gender, body mass index (BMI); New York Heart Association grade 
III or IV; previous myocardial infarction (MI) and MI within 30 days, previous percutaneous 
coronary intervention (PCI); diabetes mellitus (DM) on oral treatment or on insulin; chronic 
obstructive pulmonary disease (COPD); current smoking; serum creatinine ≥200 mmol/l, 
previous CVA; peripheral vascular disease (PVD); left main disease (LMD); number of vessel 
diseased; left ventricular ejection fraction (LVEF) between 30% and 49%; LVEF less than 
30%; non elective admission, emergent/salvage operation; preoperative IABP; off-pump 
surgery; use of additional arterial grafts and eras of surgery.  
 
Categorical variables are presented as frequencies and percentages and continuous variables as 
mean±standard deviation. Survival curves were constructed using Kaplan-Meier estimates. To 
reduce the effect of treatment selection bias and potential confounding, we adjusted for 
differences in baseline characteristics by propensity score (PS) matching [8].  
 5 
 
A PS was generated for each patient from a multivariable logistic regression model based on 
pre-treatment covariates as independent variables with treatment type (IR vs CR) as a binary 
dependent variable. The resulting propensity score represented the probability of a patient 
undergoing IR. Pairs of patients undergoing IR and CR were derived using greedy 1:1 matching 
with a calliper of width of 0.2 standard deviation of the logit of the PS  (nonrandom R package). 
The quality of the match was assessed by comparing selected pre-treatment variables in 
propensity score– matched patient using the standardized mean difference (SMD), by which 
an absolute standardized difference of greater than 10% is suggested to represent meaningful 
covariate imbalance. Analytic methods that account for the within-pair homogeneity and 
clustering effect related to individual surgeon were used for the estimation of the treatment 
effect in the matched sample. Cox proportional hazards regression stratified for PS matched 
pairs was used to investigate the effect of IR on survival (survival R package). IR of the RCA 
and the CX artery was investigated separately. Potential effect modifiers (interaction terms) 
examined were age<70 vs ≥70 years; female vs male; diabetes mellitus vs no diabetes; 
LVEF<0.50 vs ≥50%; creatinine >200mmol/l vs creatinine <200mmol/l; off-pump vs on-
pump; 3-vessel vs 2-vessel disease; left main disease vs no left main disease; use of multiple 
arterial conduits versus single arterial revascularization plus saphenous vein grafts. All p-
values <0.05 were considered to indicate statistical significance. The Schoenfeld residuals test 
was used to test the independence between residuals and time and hence to test the proportional 
hazards assumption in Cox models (all P values were >0.05). All statistical analysis were 
performed using R Statistical Software (version 3.2.3; R Foundation for Statistical Computing, 
Vienna, Austria). 
Results 
Overall, 3107 (22.7%) patients received IR. Patients’ characteristics before and after PS 
matching are reported in Table 1. Patients receiving IR were more likely to have three vessel 
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disease, receive off-pump surgery. We also find a trend towards a higher incidence of LVEF 
less than 30% and PVD in the IR group. Patients receiving CR were more likely to receive 
multiple arterial grafting. The overall number of grafts was significantly lower in the IR group. 
PS matching selected 3107 matched pairs comparable for all the baseline characteristics. Table 
2 summarizes number of grafts performed with relative targets in the CR and IR groups. Before 
matching survival rates at 5, 10 and 15 years were 86.4±0.6% versus 89.3±0.3%, 69.9±0.9% 
versus 74.7±0.5% and 51.5±1.4% versus 57.2±0.8% in the IR and CR groups respectively (HR 
1.24; 95%CI 1.15-1.34; P<0.001). Survival rates at 5, 10 and 15 years in the CR matched group 
were 88.6±0.6% 72.3± 1.0% and 51.8±1.5% with no significant difference compared to the IR 
group (HR 1.09; 95%CI 0.96-1.22; P=0.17; Figure 1 left). When the analysis was conducted 
according to the extent of IR, we found that incompletely revascularized RCA only (HR 1.06; 
95%CI 0.95-1.19) or incompletely revascularized CX artery only did not increased the risk of 
death (HR 1.04; 95%CI 0.90-1.19). However, when both RCA and CX artery were 
incompletely revascularized, late survival was significantly lower (HR 2.15; 95%CI 1.57-2.93; 
Figure 1 right).   
Subgroup analysis (Figure 2) showed that IR was associated with a higher risk of death after 
off-pump (HR 1.26; 95%CI 1.05-1.49) but not on-pump surgery (HR 0.91; 95%CI 0.75-1.1; 
interaction P=0.01). In case of off-pump surgery, incompletely revascularized RCA only (HR 
1.20; 95%CI 1.02-1.41), incompletely revascularized CX artery only (HR 1.20; 95%CI 1.01-
1.44) and concomitant incompletely revascularized RCA and CX artery (HR 2.14; 95%CI 1.48-
3.09) were associated with poorer survival. In case of on-pump surgery, when both RCA and 
CX artery were incompletely revascularized survival was significantly lower (HR 2.32; 95%CI 
1.27-4.22), but IR did not significantly affect survival in case of incompletely revascularized 
RCA only (HR 0.96; 95%CI 0.82-1.12) or incompletely revascularized CX artery only (HR 
0.90;95%CI 0.73-1.10) (Figure 3).  
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Discussion 
The main finding of the present study is that the detrimental effect of incomplete 
revascularization after CABG on survival is more relevant in subjects undergoing off-pump 
when compared to on-pump surgery. During on-pump surgery, IR affects survival only if both 
RCA and CX artery are incompletely revascularized.   
CR is a major goal in CABG based on the long-existing principle that CR is superior to IR 
regrading long-term survival to early and long-term survival [1]. The association between CR 
and lower risk for subsequent cardiovascular events may be causal. CR may improve clinical 
outcomes by reducing or eliminating myocardial ischemia, which has been linked to worse 
prognosis, especially when large [9,10]. However, IR may be a surrogate marker for higher 
burden of comorbidities and more advanced coronary artery disease that is less amenable to 
revascularization [3]. In the latter case, IR per se might not be particularly relevant on patients’ 
outcome. The likelihood of achieving CR with either CABG or percutaneous coronary 
intervention, ideally estimated by a heart team approach, should influence the decision to 
proceed with CABG or PCI [2,11]. With this approach in the SYNTAX (Synergy Between PCI 
With Taxus and Cardiac Surgery) trial [2], the rates of IR were 43.3% for PCI and 36.8% for 
CABG, which compares favorably with historical cohorts [12], while still highlighting the 
procedural complexity of achieving CR during CABG. Interestingly, in the SYNTAX trial, IR 
was found to be associated with poorer outcomes in the PCI arm but not in the CABG arm [2]. 
It has been suggested the detrimental effect of IR in the CABG population might be mitigated 
by the presence of LITA to LAD graft [3] and the use of additional arterial grafts [13]. On the 
other hand, off-pump CABG has been consistently associated with a higher incidence of 
incomplete revascularization and a trend towards poorer survival [14-18]. The present analysis 
showed that IR is more relevant when occurs in off-pump CABG than on-pump CABG. 
Common reasons for IR are based on preoperative assessment (eg, nondominant diseased right 
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coronary artery, non-vital myocardium, limited graft material), or more unexpected findings 
during the operation (ie, small target vessel, severely calcified artery). These conditions are 
anticipated to not have a major impact of outcomes. However, during off-pump CABG, 
surgeon ability plays a major role in determining the completeness of revascularization and 
vessels supplying large portion of viable myocardium can remain ungrafted.  
We here focused on the prognostic impact of IR of circumflex and right coronary artery 
territory and we found that when performing LITA-to-LAD bypass, IR does not adversely 
affect survival unless both the circumflex or right coronary artery territory are incompletely 
revascularized. However, this was true only for patients undergoing on-pump surgery while 
the detrimental effect IR on survival was more relevant after off-pump CABG. Therefore, our 
findings support the hypothesis that IR during on-pump strongly different from IR during off-
pump when good graftable vessels with large areas of viable myocardium remain untreated due 
to limited surgeon’s ability [17,18].  
A possible explanation for the lack of negative effect form IR during on-pump is that the 
progression in modern era with secondary pharmacological treatment could partially 
compensate surgical IR in diffuse distal CAD of the non-LAD territories. It has been suggested 
that the lower number of distal anastomoses might be compensated by the higher number of 
arterial grafts for non-LAD targets in IR patients [13]. However, this hypothesis has been 
recently challenged by mid-terms result of the Arterial Revascularization Trial (ART) that 
failed to show a significant benefit from using a second arterial graft for the CX territory [19]. 
Our results are in line with the ART trial and highlight the primary importance of completeness 
of revascularization in particular while performing off-pump CABG.  
Limitations 
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There are some limitations of the present study. First, it was subject to all limitations inherent 
to a nonrandomized study, including potential selection bias regarding which patients 
underwent CR versus IR. This was partially addressed by using PS matching to minimize 
residual imbalance for measured variables, but we could not account for unmeasured factors 
and in particular for targets quality. The current data lacks a standardized, universal definition 
of what constitutes an IR procedure [2-4]. Gössl et al. [20] recently proposed a universal 
definition of IR using coronary angiography and fractional-flow reserve (FFR) data. Based on 
the previous work by Piljs et al. [21] regarding the excellent long-term outcomes of patients 
with intermediate stenosis and insignificant FFR and the observation that FFR-guided PCI in 
patients with multivessel coronary artery disease is superior to angiography-guided PCI, a 
definition of IR that includes anatomy and physiology seems intuitive. However, FFR was not 
available for the present analysis. 
Conclusion.  
The present analysis showed that the impact of IR on survival is marginal when the procedure 
is performed with the use of cardiopulmonary bypass while IR after off-pump CABG remains 
associated with significantly lower survival. The worst survival rates are observed when both 
RCA and CX artery remain incompletely revascularized. These results confirm that complete 
revascularization remains the main goal while performing off-pump CABG and that off-pump 
should be avoided if CR cannot be achieved.  
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Figure Legends 
Figure 1. Survival rates in propensity matched subjects receiving complete revascularization 
(CR) vs incomplete revascularization (IR) in the overall sample (left) and impact of incomplete 
revascularization in the right coronary artery (RCA) and circumflex artery (CX) territory 
(right).  
Figure 2. Subgroup analysis of the effect of incomplete revascularization on mortality.  
Figure 3. Impact of incomplete revascularization (IR) in the right coronary artery (RCA) and 
circumflex artery (CX) territory (right) when compared to complete revascularization (CR) in 
on-pump and off-pump surgery.  
Supplementary Figure 1. Standardized mean difference before and after matching. 
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Table 1. Baseline characteristics before and after matching 
 
 IR CR SMD CR matched SMD 
 N=3107 N=10594  N=3107  
Age, mean (sd) 66.55 (9.47) 66.05 (9.27) 0.054 66.73 (8.95) 0.020 
Female, n (%) 557 (17.9) 1866 (17.6) 0.008 549 (17.7) 0.007 
BMI (mean (sd))  27.91 (4.53) 27.86 (4.42) 0.011 27.86 (4.61) 0.011 
NYHA III-IV, n (%) 965 (31.1) 3090 (29.2) 0.041 966 (31.1) 0.001 
MI 30 days, n (%) 589 (19.0) 2053 (19.4) 0.011 597 (19.2) 0.007 
PCI, n (%) 182 ( 5.9) 545 ( 5.1) 0.031 192 ( 6.2) 0.014 
DMO, n (%) 356 (11.5) 1089 (10.3) 0.038 329 (10.6) 0.028 
DMI, n (%) 257 ( 8.3) 761 ( 7.2) 0.041 253 ( 8.1) 0.005 
Smoking, n (%) 419 (13.5) 1377 (13.0) 0.014 419 (13.5) <0.001 
Cr>200mmol/l, n (%) 99 ( 3.2) 257 ( 2.4) 0.046 111 ( 3.6) 0.021 
COPD, n (%) 267 ( 8.6) 795 ( 7.5) 0.040 273 ( 8.8) 0.007 
CVA, n (%) 128 ( 4.1) 391 ( 3.7) 0.022 118 ( 3.8) 0.017 
PVD, n (%) 358 (11.5) 1025 ( 9.7) 0.060 358 (11.5) <0.001 
LVEF31-49%, n (%) 731 (23.5) 2290 (21.6) 0.046 731 (23.5) <0.001 
LVEF ≤30%, n (%) 198 ( 6.4) 522 ( 4.9) 0.063 207 ( 6.7) 0.012 
Non-elective, n (%) 1503 (48.4) 5054 (47.7) 0.013 1504 (48.4) 0.001 
Emergent, n (%) 56 ( 1.8) 165 ( 1.6) 0.019 56 ( 1.8) <0.001 
Preop IABP, n (%) 45 ( 1.4) 155 ( 1.5) 0.001 44 ( 1.4) 0.003 
NVD, n (%)   0.502  <0.001 
     2  383 (12.3) 3421 (32.3)  383 (12.3)  
     3  2724 (87.7) 7173 (67.7)  2724 (87.7)  
LMD, n (%) 810 (26.1) 2829 (26.7) 0.014 826 (26.6) 0.012 
OPCAB, n (%) 1751 (56.4) 4978 (47.0) 0.188 1729 (55.6) 0.014 
MAG, n (%) 565 (18.2) 2462 (23.2) 0.125 533 (17.2) 0.027 
Eras, mean (sd)  2004.92 (5.12) 2004.92 (5.28) 0.001 2004.98 (5.06) 0.012 
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Table 2. Number of grafts and targets in CR and IR groups.  
 CR IR P 
2-vessel disease, n 383 383  
N grafts, mean (sd) 2.18 (0.40) 1.56 (0.51) <0.001 
CX artery, n (%) 223 (58.2) 14 ( 3.7) <0.001 
RCA, n (%) 179 (46.7) 20 ( 5.2) <0.001 
    
3-vessel disease, n  2724 2724  
N grafts, mean (sd) 3.26 (0.47) 2.58 (0.62) <0.001 
CX artery, n (%) 2723 (100.0) 1761 (64.6) <0.001 
RCA, n (%) 2724 (100.0) 911 (33.4) <0.001 
 
